BALANCE-AAD-1: A Phase 2, Randomized, DB, 3-Arm, PC, Multicenter Study Assessing the Efficacy, Safety & Tolerability of orally administered BMS-986368, a FAAH/MGLL Inhibitor, for the treatment of Agitation in Participants with Alzheimer's